Presentation is loading. Please wait.

Presentation is loading. Please wait.

URDANETA CITY UNIVERSITY`. COLLEGE OF PHARMACY PHARMACY INFORMATICS MIDTERM PROJECT.

Similar presentations


Presentation on theme: "URDANETA CITY UNIVERSITY`. COLLEGE OF PHARMACY PHARMACY INFORMATICS MIDTERM PROJECT."— Presentation transcript:

1 URDANETA CITY UNIVERSITY`

2 COLLEGE OF PHARMACY

3 PHARMACY INFORMATICS MIDTERM PROJECT

4

5 CLOPIDOGREL BISULFITE CLOTIZ® INDICATIONS: PREVENTION OF ATHERSCLEROTICEVENTS IN PERIPHERALARTERIAL DISEASES OR WITHIN 3 DAYS OF MI, OR WITHIN 6 MONTH OF ISCHEMIC STROKE OR IN ACUTE CORONARY SYNDROME WITHOUT ST-SEGMENT ELEVATION.

6 CLOPIDOGREL BISULFITE CLOTIZ® CONTRAINDICATIONS: ACTIVE PATHOLOGICAL BLEEDING OF PEPTIC ULCER OR INTRACRANIAL HEMORRHAGE. PRECAUTION: PATIENTS WHO MAYBE AT RISK OF INCREASE BNLEEDING FROM TRAUMAS, SURGERYOR OTHER PATHOLOGICAL CONDITIONS. SIDE EFFECTS: HEMORRHAGE, NEUROTROPENIA, GASTRITIS, DYSPEPSIA, CONSTIPATION, SKIN RASHES AZND CHEST PAIN

7 CLOPIDOGREL BISULFITE CLOTIZ® MANUFACTURED BY: CHIRA PHARMA

8 BIXALAX CIPLA® INDICATIONS: CONSTIPATION. SPECIAL PRECAUTIONS: PATIENTS WITH ANAL FISSURES, PROCTITIS OR ULCERATED HEMORRHOIDS; PROLONGED USEDOR OVERDOSE MAY CAUSE DIARRHEA WITH EXCESSIVE WATER AND ELECTROLYTES LOSS AND ATONIC NON-FUNCTIONING COLON MAY DEVELOP.

9 BIXALAX CIPLA® SIDE EFFECTS: IRRITATION; REPEATED USE MAY CAUSE PROCTITIS OR SLOUGHINGOF THE EPITHELIUM. MANUFACTURED BY: PHIL PHARMAWEALTH

10 IBUPROFEN ALAXAN® INDICATIONS: RELIEF OF MILD TO MODERATELY SEVERE PAIN OF MUSCULOSKELETAL ORIGIN, MUSCLE PAIN, ARTHRITIS, RHEUMATISM, SPRAIN, STRAIN, BURSITIS, TENDONITIS, BACKACHE, STIFF NECK, TENSION HEADACHE, DYSMENORRHEA, TROOTHACHE AND REDUCTION OF FEVER.

11 IBUPROFEN ALAXAN® CONTRAINDICATIONS: PATIENTS IN WHOM BRONCHOSPASM, ANGIOEDEMA OR NASAL POLYPSARE PRECIPITATEDBY IBUPROFEN, ASPIRIN AND OTHER NSAIDS. ADVANCED LIVER AND KIDNEY DISEASES. SIDE EFFECTS: GI, RENAL, HEPATIC, CNS, OTIC AND OCULAR, DERMATOLOGIC EFFECTS. FLUID RETENTION, INCREASED BLOOD PRESSURE, HYPOTENSION, CVA AND PALPITATIONS. MANUFACTURER: UNITED LABORATIES

12 LORATADINE ALLERTA TABLET® INDICATIONS: RELIEF OF SYMPTOMS ASSOCIATED WITH ALLERGIC RHINITIS. TREATMENT OF CHRONIC IDIOPATHIC, URTICARIA AND OTHER ALLERGIC DERMATOLOGIC DISORDERS. PRECAUTIONS: RENAL AND HEPATIC INSUFFICIENCY.

13 LORATADINE ALLERTA TABLET® SIDE EFFECTS: FATIGUE, DIZZINESS, DRY MOUTH, HEADACHE, SEDATION, NAUSEA, AND PRURITUS. MANUFACTURED BY: AMHERST LAB

14 MICONZOLE DAKTARIN ORAL GEL® INDICATIONS: CURATIVE AND PROPHYLACTIC TREATMENT OF CANDIDOSISOF THE ORAL OROPHARYNGEAL CAVITY AND GIT. CONTRAINDICATION: LIVER DYSFUNCTION.

15 MICONZOLE DAKTARIN ORAL GEL® DRUG INTERACTIONS: TERFENADINE, ASTEMIZOLE, MIZOLASTINE, CISAPRIDE, TRIAZOLAM, ORAL MIDAZOLAM, DOFETILIDE, QUINIDINE, PRIMOZIDE, SIMVASTATIN, LOVASTATIN, ORAL ANTICOAGULANTS. MANUFACTURED BY: JANSSEN(ZUELLIG)

16 METOCLOPRAMIDE HCL METSIL® INDICATIONS: MANAGEMENT OF DECREASED GI MOTILITY GASTOPARESIS OR ILEUS, GERD, DYSPEPSIA; NAUSEA AND VOMITTING ASSOCIATED WITH VARIOUS GI DISORDERS, MIGRAINE, POST-0OPSURGERY AND CANCER THERAPY. CONTRAINDICATIONS: PHAEOCHROMOCYTOMA. GI HEMORRHAGE AND MECHANICAL OBSTRUCTION OR PERFORATION. HYPERSENSITIVITY TO PROCAINE AND PROCAINAMIDE. EPILEPSY AND PORPHYRIA. DRUGS THAT ARE LIKELY TO PRODUCE PYRAMIDIAL REACTIONS.

17 METOCLOPRAMIDE HCL METSIL® PRECAUTIONS: PARKINSONS DISEASE, RENAL IMPAIREMENT AND HISTORY OF DEPRESSION. MAY IMPAIR THE ABILITY TO DRIVE OR OPERATE MACHINERY. AVOID PROLONGED THERAPY. SIDE EFFECTS: DYSTONIC REACTIONS; PARKINSONISM AND TARDIVE DYSKINESIA; HYPOTENSION, HYPERTENSION, DIZZINESS, HEADACHEAND DEPRESSION. MANUFACTURED BY: SINOCHEM NINGBO(2 WORLD TRADERS)

18 TRANYLCYPROMINE TRANYLCYPROMINE® INDICATIONS: DEPRESSIVE ILLNESS. CONTRAINDICATIONS: HEPATIC IMPAIREMENT OR ABNORMAL LIVER FUNCTIONTESTS, CEROBROVASCULARDISEASE, PHAECHROMOCYTOMA.

19 TRANYLCYPROMINE TRANYLCYPROMINE® SIDE EFFECTS: COMMONLY POTURAL HYPOTENSION DIZZINESS; LESS COMMON SIDE EFFECTS INCLUDE DROWSINESS, INSOMIA, HEADACHE, FATIGUE, DRY MOUTH CONSTIPATION AND OTHER GASTROINTESTINAL DISTURBANCES…

20 ZIPRASIDONE GEODON® INDICATIONS: SYMPTOMATIC TREATMENT OF SCHIZOPRENIA. RAPID CONTROL OF ACUTE AGITATION IN SCHIZOPHRENIC PATIENTS. CONTRAINDICATIONS: CONTRINDICATED IN PATIENTS HYPERSENSITIVE TO DRUG AND IN THOSE WITH RECENT MI OR UNCOMPENSATED HEART FAILURE.

21 ZIPRASIDONE GEODON® CAUTIONS: USE CAUTIOUSLY IN PATIETS AT RISK FOR ASPIRATION PNEUOMONIA. SIDE EFFECTS: EXTRA PYRAMIDAL SYMPTOMS, HYPERTONIA, ASTHENIA; DYSTONIA, HEADACHE, DIZZINESS, ANXIETY AND SUICIDE ATTEMPT, INSOMNIA.

22 TROSPIUM SANCTURA® INDICATIONS: Treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and urinary frequency. CONTRAINDICATIONS: Contraindicated in patients with urinary retention, gastric retention, uncontrolled narrow-angle glaucoma.

23 TROSPIUM SANCTURA® SIDE EFFECTS: Dry mouth, constipation, stomach upset, headache, dry eyes, dizziness, blurred vision, or drowsiness may occur.

24 CIPROFLOXACIN CIFLOX® INDICATIONS: Treatment for certain types of bacterial infections such as pneumonia, urinary tract, skin, bones and joint infections. It is also used to treat gastrointestinal infections. CONTRAINDICATIONS: Avoid administration with tizanidine, and in patients with hypersensitivity.

25 CIPROFLOXACIN CIFLOX® CAUTIONS: Should be exercised in patients with history of stomach infection, liver problems, brain or nervous system problems, increased pressure in the brain. SIDE EFFECTS: Nausea, diarrhea, abnormal liver function tests, vomiting and rash.


Download ppt "URDANETA CITY UNIVERSITY`. COLLEGE OF PHARMACY PHARMACY INFORMATICS MIDTERM PROJECT."

Similar presentations


Ads by Google